Commerzbank Aktiengesellschaft’s Lexicon Pharmaceuticals LXRX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,503	Closed	-$36K	–	1204
2015 Q1	$36K	Buy	5,503 +2,867	+109%	+$19.6K	﹤0.01%	1139
2014 Q4	$17K	Buy	2,636 +1,171	+80%	+$9.44K	﹤0.01%	1160
2014 Q3	$15K	Buy	+1,465	New	+$15.6K	﹤0.01%	1123
2013 Q3	–	Sell	-2,257	Closed	-$34K	–	1362
2013 Q2	$34K	Buy	+2,257	New	+$34.3K	﹤0.01%	1443

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Commerzbank Aktiengesellschaft's LXRX Position: Q2 2015 in Review

Commerzbank Aktiengesellschaft sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 5,503 shares — an estimated $36K sold.

Commerzbank Aktiengesellschaft first reported a position in LXRX in Q2 2013 and held it in 4 quarters. The position peaked at $36K in Q1 2015. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

Commerzbank Aktiengesellschaft reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 5,503 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $36K.
Commerzbank Aktiengesellschaft first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Commerzbank Aktiengesellschaft's Lexicon Pharmaceuticals position peaked at $36K in Q1 2015.
94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2015, filed 10 Aug 2015.